PMID: 8306085Dec 1, 1993

Effects of sumatriptan on the cerebral intraparenchymal microcirculation in the cat

British Journal of Pharmacology
M KobariH Takeda


1. Sumatriptan, a 5-hydroxytryptamine (5-HT)1-like receptor agonist, is effective against the headache of migraine. The effects of sumatriptan injected via the carotid artery on the cerebral microcirculation were studied in 10 anaesthetized cats. 2. The local cerebral blood volume (CBV), mean transit time of blood (MTT) and cerebral blood flow (CBF) in the parieto-temporal cortex were measured by a photoelectric method. CBV represents the cumulative dimensions of the cerebral microvessels. 3. Sumatriptan at 5 and 50 micrograms kg-1 had no significant effects on the CBV, MTT, CBF, and mean arterial blood pressure (MABP); 500 micrograms kg-1 of sumatriptan reduced the CBV, prolonged the MTT, and decreased the CBF (approximately -20%) without affecting the MABP. Sumatriptan, 5 mg kg-1, elicited transient reductions in CBV and CBF, which were attributable to the rapid and marked falls of MABP seen with this dose. 4. Thus, while a high dose of sumatriptan (500 micrograms kg-1) exhibits direct vasoconstrictor actions on the cerebral vessels, low doses of sumatriptan, within the therapeutic range, elicit no vasoconstriction. The data do not support a vasoconstrictor action of sumatriptan playing a primary role in reversing the headach...Continue Reading


Sep 29, 1999·Journal of the Neurological Sciences·H BaeznerM Hennerici
Nov 1, 1996·Progress in Neurobiology·Z CohenE Hamel
Feb 1, 1997·Clinical Neurology and Neurosurgery·S al DeebP Cheung
May 1, 1996·Acta Anaesthesiologica Scandinavica·F NilssonC H Nordström
Mar 1, 1995·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M D Ferrari, P R Saxena
Jan 28, 2004·British Journal of Pharmacology·Richard J DavisRobert A Coleman
Jan 18, 2005·Journal of Neuroimmunology·D DubayleD Menétrey
May 18, 1999·NeuroImage·A MayR S Frackowiak
Jul 23, 2002·Cephalalgia : an International Journal of Headache·M FukudaF Sakai
Jun 1, 1996·Cephalalgia : an International Journal of Headache·H HenkesH C Diener
May 28, 2019·Pharmacological Reports : PR·Anna Koldbro HanstedInger Jansen-Olesen


May 1, 1992·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·H E ConnorP P Humphrey
Apr 1, 1992·British Journal of Clinical Pharmacology·A K ScottA J Pilgrim
Aug 1, 1992·Cephalalgia : an International Journal of Headache·I JansenJes Olesen
Aug 1, 1992·Trends in Pharmacological Sciences·M A Moskowitz
Dec 1, 1991·Trends in Pharmacological Sciences·P P Humphrey, W Feniuk
Sep 28, 1991·Lancet·P J GoadsbyJ W Lance
Jun 15, 1991·JAMA : the Journal of the American Medical Association·R K CadyH Skaggs
Aug 1, 1991·Trends in Pharmacological Sciences·Andrew A Parsons
Jan 1, 1990·Annals of the New York Academy of Sciences·P P HumphreyE T Whalley
Jan 1, 1989·British Journal of Pharmacology·W FeniukM J Perren
Feb 1, 1989·British Journal of Pharmacology·Andrew A ParsonsP P Humphrey
Oct 1, 1988·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M TomitaI Gerdsen

Related Concepts

Cerebral Blood Flow Imaging
Pathologic Vasoconstriction
Cerebrovascular System
Common Carotid Artery
Entire Carotid Artery
Status Migrainosus

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.

Related Papers

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
H E ConnorP P Humphrey
British Journal of Clinical Pharmacology
A K ScottA J Pilgrim
© 2020 Meta ULC. All rights reserved